title: Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
abstract: A 31-year-old man with dilated cardiomyopathy was hospitalized for new-onset atrial fibrillation. Oral amiodarone 600 mg/day was started to control his arrhythmia, and the patient continued to receive digoxin 0.125 mg/day, which was prescribed 4 days earlier at a heart failure clinic. The patient's digoxin plasma concentration peaked early on hospital day 3 at 2.93 ng/ml; digoxin was withheld. Over the next 3 days, the patient's digoxin plasma concentrations rose and fell daily. These fluctuations correlated with the timing of blood sampling in relation to oral amiodarone administration. The patient's renal function remained stable, and he developed no signs or symptoms of digoxin toxicity. To our knowledge, no case reports have associated significant fluctuations of digoxin plasma concentrations that correspond to the timing of oral amiodarone administration. Tissue-to-plasma redistribution appears to be a possible mechanism for this interaction, with the most significant effect occurring 8-10 hours after amiodarone administration. Clinicians should be aware that digoxin plasma concentrations may not correlate with digoxin tissue concentrations in this setting. When a loading dose of oral amiodarone is required in a patient receiving digoxin, the digoxin dosage should first be reduced, and digoxin therapy should be adjusted based on signs and symptoms of digoxin toxicity.
authors.affiliation: Pharmacy Department, Blank Children's Hospital, Des Moines, Iowa, USA.
authors.forename: Kelli J
authors.initials: KJ
authors.lastname: DeVore
authors.forename: Ryan A
authors.initials: RA
authors.lastname: Hobbs
mesh_terms: D000328:Adult; D000638:Amiodarone / Q000009:adverse effects / Q000097:blood* / Q000493:pharmacokinetics; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000097:blood* / Q000493:pharmacokinetics; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002311:Cardiomyopathy, Dilated; D004077:Digoxin / Q000009:adverse effects / Q000097:blood* / Q000493:pharmacokinetics; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D008297:Male; D013997:Time Factors
chemical_list: D000889:Anti-Arrhythmia Agents; D004077:Digoxin; D000638:Amiodarone